NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today provided a ...
NORWALK, Conn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for November 2025. The report, which tracks the issuance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback